Michael T. Andriole, President and CEO of Chimerix Inc . (NASDAQ:CMRX), recently sold 7,370 shares of the company's common stock, according to a recent SEC filing. The shares were sold at a weighted ...
Joshua Schafer, Chief Commercial Officer and Executive Vice President of Business Development at Zevra Therapeutics, Inc. (NASDAQ:ZVRA), sold 10,500 shares of the company's common stock on February 13 ...
Some political leaders in Canada want to rekindle pipeline projects in the face of U.S. tariffs threatening the country’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback